COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,635 Articles (22,913 medRxiv, 8,722 bioRxiv)

Most recent first Previous |  Page 1841: Articles 18401-18410  | Next

A multi-centre service evaluation of the impact of the COVID-19 pandemic on presentation of newly diagnosed cancers and type 1 diabetes in children in the UK
COVID-19 Pandemic UK-based Interest Group of Childhood Cancer and Diabetes, , Williams, G., McLean, R., Liu, J.-F., Ritzmann, T., Dandapani, M., Sachdev, P., Brougham, M., Mitchell, R., Conway, N. T., Law, J., Cunnington, A., Ogunnaike, G., Brougham, K., Bayman, E., Walker, D. A.
10.1101/2021.02.09.21251149 — Posted: 2021-02-16
Fear and death anxiety among Latin American doctors during the Covid-19 pandemic
Perez, M. A., Indacochea, S., Torres-Malca, J. R., Vera-Ponce, V. J., De La Cruz-Vargas, J. A.
10.1101/2021.02.12.21251445 — Posted: 2021-02-16
Responsive caregiving, opportunities for early learning, and children's safety and security during COVID-19: A rapid review
Proulx, K., Lenzi-Weisbecker, R., Rachel, R., Hackett, K., Cavallera, V., Daelmans, B., Dua, T.
10.1101/2021.02.10.21251507 — Posted: 2021-02-16
An alternative approach for bioanalytical assay development for wastewater-based epidemiology of SARS-CoV-2
Tim, B., Jacobs, L., De Roeck, N., Van den Bogaert, S., Aertgeerts, B., Lahousse, L., van Nuijs, A. L. N., Delputte, P.
10.1101/2021.02.12.21251626 — Posted: 2021-02-16
Workplace measures against COVID-19 during the winter third wave in Japan: company size-based differences
Ishimaru, T., Nagata, M., Hino, A., Yamashita, S., Tateishi, S., Tsuji, M., Ogami, A., Matsuda, S., Fujino, Y.
10.1101/2021.02.14.21251716 — Posted: 2021-02-16
Community end-of-life care during the COVID-19 pandemic: Initial findings of a UK primary care survey
Mitchell, S., Oliver, P., Gardiner, C., Khan, D., Chapman, H., Boyd, K., Dale, J., Barclay, S., Mayland, C.
10.1101/2021.02.15.21251756 — Posted: 2021-02-16
ImplemeNting SARS-CoV-2 Rapid antigen testing in the Emergency wArd of a Swiss univErsity hospital: the INCREASE study
Caruana, G., Croxatto, A., Kampouri, E., Kritikos, A., Opota, O., Foerster, M., Brouillet, R., Senn, L., Lienhard, R., Egli, A., Pantaleo, G., Carron, P.-N., Greub, G.
10.1101/2021.02.10.21250915 — Posted: 2021-02-15
C-reactive protein guided use of procalcitonin in COVID-19
Houghton, R., Moore, N., Williams, R., El-Bakri, F., Peters, J., Mori, M., Vernet, G., Lynch, J., Lewis, H., Tavener, M., Durham, T., Bowyer, J., Saeed, K., Pollara, G.
10.1101/2021.02.10.21251350 — Posted: 2021-02-15
Pooled Surveillance Testing Program for Asymptomatic SARS-CoV-2 Infections in K-12 Schools and Universities
Bi, C., Mendoza, R., Cheng, H.-T., Pagapas, G., Gabutan, E., Khan, N., Hoxie, H., Holmes, K., Gao, N., Lewis, R., Wang, H., Neumann, D., Chan, A., Takizawa, M., Lowe, J., Chen, X., Kelly, B., Asif, A., Barnes, K., Khan, N., May, B., Wright, M., Chowdhury, T., Pollonini, G., Gouda, N., Guy, C., Gordon, C., Ayoluwa, N., Colon, E., Miller-Medzon, N., Jones, S., Hossain, R., Dodson, A., Wang, M., McGaskey, M., Vasileva, A., Seibel, S., Connolly, J., Esposito, M., Kim, J., Lincoln, A. E., Sikka, R., Wyllie, A. L., Berke, E. M., Libien, J., Pincus, M., Premsrirut, P. K.
10.1101/2021.02.09.21251464 — Posted: 2021-02-15
Human liver organoid derived intra-hepatic bile duct cells support SARS-CoV-2 infection and replication and its comparison with SARS-CoV
Lui, V. C.-H., Hui, K. P.-Y., Babu, R. O., Yue, H., Chung, P. H.-Y., Tam, P. K.-H., Chan, M. C.-W., Wong, K. K.-Y.
10.1101/2021.02.10.21251458 — Posted: 2021-02-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).